171 related articles for article (PubMed ID: 31824148)
1. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
[TBL] [Abstract][Full Text] [Related]
2. Development of novel apoferritin formulations for antitumour benzothiazoles.
Breen AF; Wells G; Turyanska L; Bradshaw TD
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1155. PubMed ID: 32721126
[TBL] [Abstract][Full Text] [Related]
3. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.
Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF
Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393
[TBL] [Abstract][Full Text] [Related]
4. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling.
Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD
J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.
Wang K; Guengerich FP
Chem Res Toxicol; 2012 Aug; 25(8):1740-51. PubMed ID: 22734839
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.
Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L
ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826
[TBL] [Abstract][Full Text] [Related]
7. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
[TBL] [Abstract][Full Text] [Related]
9. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
[TBL] [Abstract][Full Text] [Related]
10. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models.
Fichtner I; Monks A; Hose C; Stevens MF; Bradshaw TD
Breast Cancer Res Treat; 2004 Sep; 87(1):97-107. PubMed ID: 15377855
[TBL] [Abstract][Full Text] [Related]
11. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
Stone EL; Citossi F; Singh R; Kaur B; Gaskell M; Farmer PB; Monks A; Hose C; Stevens MF; Leong CO; Stocks M; Kellam B; Marlow M; Bradshaw TD
Bioorg Med Chem; 2015 Nov; 23(21):6891-9. PubMed ID: 26474663
[TBL] [Abstract][Full Text] [Related]
12. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.
Bradshaw TD; Westwell AD
Curr Med Chem; 2004 Apr; 11(8):1009-21. PubMed ID: 15078163
[TBL] [Abstract][Full Text] [Related]
13. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.
Brantley E; Antony S; Kohlhagen G; Meng L; Agama K; Stinson SF; Sausville EA; Pommier Y
Cancer Chemother Pharmacol; 2006 Jul; 58(1):62-72. PubMed ID: 16331501
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
[TBL] [Abstract][Full Text] [Related]
16. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
[TBL] [Abstract][Full Text] [Related]
17. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells.
Quilles Junior JC; Carlos FDRR; Montanari A; Leitão A; Mignone VW; Arruda MA; Turyanska L; Bradshaw TD
RSC Adv; 2019 Nov; 9(63):36699-36706. PubMed ID: 35539052
[TBL] [Abstract][Full Text] [Related]
18. New Treatments in Renal Cancer: The AhR Ligands.
Itkin B; Breen A; Turyanska L; Sandes EO; Bradshaw TD; Loaiza-Perez AI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443455
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI
J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540
[TBL] [Abstract][Full Text] [Related]
20. 2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines.
Dubey R; Shrivastava PK; Basniwal PK; Bhattacharya S; Moorthy NS
Mini Rev Med Chem; 2006 Jun; 6(6):633-7. PubMed ID: 16787373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
